| NCT ID | NCT05520762 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Montefiore Medical Center |
| Condition | Cardiac Arrest |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,060 participants |
| Start Date | 2023-02-10 |
| Primary Completion | 2027-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,060 participants in total. It began in 2023-02-10 with a primary completion date of 2027-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Hospital Airway Resuscitation Trial (HART) is a cluster-randomized, pragmatic trial of advanced airway management with a strategy of first choice supraglottic airway vs. first choice endotracheal intubation during in-hospital cardiac arrest.
Eligibility Criteria
Inclusion Criteria: 1. Adult aged \>=18 years 2. Admitted to the hospital for any condition 3. Suffered in-hospital cardiac arrest (loss of pulse and ≥2 minutes of chest compressions) 4. Need for assisted ventilation (defined by initiation of bag-mask-ventilation or other supported ventilation) Exclusion Criteria: 1. Cardiac arrest in the Operating Room or other area not responded to by Critical Care/Emergency Department (ED) teams. 2. Cardiac arrest in which an invasive airway (i.e. endotracheal tube, tracheostomy tube) is already in place 3. Patients with Do Not Resuscitate or Do Not Intubate orders
Contact & Investigator
Ari Moskowitz, MD
PRINCIPAL INVESTIGATOR
Montefiore Medical Center
Frequently Asked Questions
Who can join the NCT05520762 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cardiac Arrest. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05520762 currently recruiting?
Yes, NCT05520762 is actively recruiting participants. Contact the research team at amoskowitz@montefiore.org for enrollment information.
Where is the NCT05520762 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT05520762 clinical trial?
NCT05520762 is sponsored by Montefiore Medical Center. The principal investigator is Ari Moskowitz, MD at Montefiore Medical Center. The trial plans to enroll 1,060 participants.